• English
  • Eesti

The Estonian medicinal products market in second quarter 2019

15.08.2019
Printer-friendly version

Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

Human medicines

In the second quarter of 2019 the medicinal products market increased 8.0% reaching to 86.7 million euros. Estonian human medicines market of previous five years shows also an increasing trend:


Figure 1. Estonian human medicines market in second quarter 2015–2019

Sales to general pharmacies were 59.4 million euros, sales to hospital pharmacies 26.5 million euros and sales to other institutions 0.8 million euros.

Prescription sales covered most of the medicinal products market, being 75.4 million euros. The turnovers of over the counter sales and hospital package sales were 10.9 million euros and 0.5 million euros.

Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (19.0 million euros), antiinfectives for systemic use (14.1 million euros) and alimentary tract and metabolism medicines (9.5 million euros).

Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

According to DDD/1000/day the most consumed medicines in the second quarter of 2019 were cardiovascular system drugs (430 DDD/1000/day), alimentary tract and metabolism drugs (172 DDD/1000/day) and nervous system medicines (131 DDD/1000/day).

In the second quarter of 2019, almost 3700 different medicinal preparation packages and 1200 active substances were marketed in Estonia.

Veterinary medicines

In the second quarter of 2019 the Estonian veterinary medicinal products market increased 8.8% compared to the same period in 2018 reaching to 4.2 million euros.

The most sold medicines by turnover were antiparasitic products (1.36 million euros), followed by antiinfectives for systemic use (0.83 million euros) and immunologicals (0.81 million euros).

79% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 12% to the general pharmacies, 7% to the veterinary pharmacies and 3% to other institutions (generally state- and scientific institutions).


Figure 2. Estonian veterinary medicinal products market in second quarter 2015–2019